InvestorsHub Logo
Followers 71
Posts 2156
Boards Moderated 0
Alias Born 12/12/2013

Re: C to the E post# 105242

Tuesday, 07/25/2017 5:40:24 AM

Tuesday, July 25, 2017 5:40:24 AM

Post# of 203914
Amazing the new Chairman has right connections with BOG PHARMA, M&A and worked in NASDAQ company and has experience with commercialisation of skin diseases products!!

From 8-k:
"
From May 2016 to the present, Dr. Hirsch has served as Chairman of the Board of Directors of Foamix Pharmaceuticals Ltd (NASDAQ: FOMX), an Israeli-based clinical-stage specialty pharmaceutical company in late-stage clinical development and commercializing two proprietary products for the treatment of acne, rosacea and other skin conditions. Foamix collaborates with leading global pharmaceutical companies in the creation and commercialization of its advanced skin treatment products.
"

OWCP GOING TO DOLLARS FOR PATIENT INVESTORS